Article
San Francisco - Two large phase III studies involving 15 percent azelaic gel (Finacea) for the treatment of rosacea each resulted in more than a 50-percent reduction in the number of lesions.
Dermatology Times November 2024 Print Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Advances in HS treatment with Chris Sayed, MD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Hydroquinone Pigmentation Alternatives
Polynucleotide Therapy Shows Promise in Scar and Burn Management